The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis

J Infect. 2023 Jan;86(1):e15-e17. doi: 10.1016/j.jinf.2022.08.021. Epub 2022 Aug 27.
No abstract available

Publication types

  • Meta-Analysis
  • Systematic Review
  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • COVID-19*
  • Classification
  • Humans

Substances

  • tixagevimab
  • cilgavimab
  • Antibodies, Monoclonal